These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15891564)

  • 21. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
    West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
    BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ; Stinson D; Staehle B; Cho I; Matthews H; Ngai A; Keller P; Eiden J; Kuter B
    Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
    Aytac S; Yalcin SS; Cetin M; Yetgin S; Gumruk F; Tuncer M; Yurdakok K; Gurgey A
    Pediatr Hematol Oncol; 2010 Aug; 27(5):333-43. PubMed ID: 20469978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parental Vaccine Hesitancy and Association With Childhood Diphtheria, Tetanus Toxoid, and Acellular Pertussis; Measles, Mumps, and Rubella; Rotavirus; and Combined 7-Series Vaccination.
    Nguyen KH; Srivastav A; Lindley MC; Fisher A; Kim D; Greby SM; Lee J; Singleton JA
    Am J Prev Med; 2022 Mar; 62(3):367-376. PubMed ID: 35190101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA.
    Groves FD; Gridley G; Wacholder S; Shu XO; Robison LL; Neglia JP; Linet MS
    Br J Cancer; 1999 Sep; 81(1):175-8. PubMed ID: 10487630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, blinded, placebo-controlled trial comparing antibody responses to homeopathic and conventional vaccines in university students.
    Loeb M; Russell ML; Neupane B; Thanabalan V; Singh P; Newton J; Pullenayegum E
    Vaccine; 2018 Nov; 36(48):7423-7429. PubMed ID: 30352746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination.
    Boulianne N; De Serres G; Ratnam S; Ward BJ; Joly JR; Duval B
    Vaccine; 1995 Nov; 13(16):1611-6. PubMed ID: 8578850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age.
    Dagan R; Igbaria K; Piglansky L; Van Brusteghem F; Melot V; Kaufhold A
    Vaccine; 1999 Jun; 17(20-21):2620-7. PubMed ID: 10418911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diphtheria-Tetanus-Polio, Measles-Mumps-Rubella, and Hepatitis B Vaccination Coverage and Associated Factors among Homeless Children in the Paris Region in 2013: Results from the ENFAMS Survey.
    Mansor-Lefebvre S; Le Strat Y; Bernadou A; Vignier N; Guthmann JP; Arnaud A; Lévy-Bruhl D; Vandentorren S
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326203
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.
    Stratton KR; Howe CJ; Johnston RB
    JAMA; 1994 May; 271(20):1602-5. PubMed ID: 8182813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia.
    Volc SM; Almeida MT; Abadi MD; Cornacchioni AL; Odone Filho V; Cristofani LM
    J Pediatr (Rio J); 2006; 82(6):481-4. PubMed ID: 17003944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza.
    Gillum JE; Garrison MW; Crossley KB; Rotschafer JC
    Postgrad Med; 1989 Feb; 85(2):183-6, 188-90, 195-8. PubMed ID: 2783777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fifth vaccination with dipthteria, tetanus and acellular pertussis is beneficial in four- to six-year-olds.
    Pichichero ME; Anderson EL; Rennels MB; Edwards KM; England JA
    Pediatr Infect Dis J; 2001 Apr; 20(4):427-33. PubMed ID: 11332669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
    Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O
    Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited Impact of Human Cytomegalovirus Infection in African Infants on Vaccine-Specific Responses Following Diphtheria-Tetanus-Pertussis and Measles Vaccination.
    Cox M; Adetifa JU; Noho-Konteh F; Njie-Jobe J; Sanyang LC; Drammeh A; Plebanski M; Whittle HC; Rowland-Jones SL; Robertson I; Flanagan KL
    Front Immunol; 2020; 11():1083. PubMed ID: 32582177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine.
    Simoes EA; Balraj V; Selvakumar R; John TJ
    Am J Dis Child; 1988 Mar; 142(3):309-11. PubMed ID: 3257842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.